Innovi Sas

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Innovi Sas - overview

Established

1996

Location

-, -, France

Primary Industry

Consumer Products

About

Cosmos-Innovi is a French company specializing in research, development, and production in health-related ecosystems, focusing on innovative solutions in nutrition, personal care, and sustainable materials. Founded in 1996 in France, Cosmos-Innovi operates in the health-related sector, providing research and development services. The company received a Growth funding round in September 2013, attracting EUR 0. 80 mn from M Capital.


It has completed a total of 1 deal, indicating a focused investment strategy. Laboratoires Innovi specializes in research, development, and production across various health-related ecosystems. The company focuses on several core product categories, including plant nutrition, human food and nutrition, dietary supplements, personal care, and bio-sourced materials. Innovi engages in creating new concepts, products, and processes tailored to meet the demands of these sectors.


Their offerings aim to enhance health outcomes by improving nutritional quality, developing effective cosmetic solutions, and providing sustainable material alternatives. Innovi serves a diverse client base consisting of food producers, cosmetic manufacturers, and agricultural companies, primarily operating in European markets, including France and neighboring countries. In 2019, Cosmos-Innovi reported a revenue of EUR 4,042,441. 90, with an EBITDA amounting to EUR 2,268,956.


70. The company’s revenue model revolves around providing tailored research and development services and product testing to its clients. It engages in B2B transactions, collaborating directly with manufacturers in the health and beauty sectors, which form a significant portion of their earnings. Cosmos-Innovi is actively designing new products aimed at the health and nutrition sectors, with anticipated launches in the upcoming year.


The company plans to expand into new geographic markets, particularly targeting regions in Europe, aiming for completion by 2025. The recent funding of EUR 0. 80 mn will be utilized to support these initiatives, including new product development and market expansion efforts.


Current Investors

Primary Industry

Consumer Products

Sub Industries

Consumer Products

Website

www.groupe-innovi.fr

Verticals

Manufacturing

Company Stage

Mature - Growth Capital

Total Amount Raised

Subscriber access only

Innovi Sas - financials

Fiscal Year EndedDec 31, 2016Dec 31, 2017Dec 31, 2018Dec 31, 2019
Revenue (USD)592,700.4---
% Revenue Growth (YoY)----
EBITDA (USD)204,662.3---
Operating Income (USD)128,183.9---
Operating Margin21.6%---
% EBITDA Margin34.5%---
NET Income (USD)424,671.7---
% Net Margin71.7%---

Innovi Sas - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
GrowthCompletedInnovi Sas-

Displaying 1 - 1 of 1

Innovi Sas - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.